BCRX : Analysis & Opinions

  1. UCB's New Epilepsy Drug Under Review in the U.S., EU - Analyst ...

    January 22, 2015
    UCB S.A. (UCBJF) announced that its investigational antiepileptic candidate, brivaracetam, has been accepted for review in ...
  2. BioCryst's BCX4161 Recommended for Orphan Drug in EU - Analyst ...

    January 15, 2015
    BioCryst Pharmaceuticals, Inc. (BCRX) received a positive opinion regarding its application for orphan drug status for BCX4161 ...
  3. BioCryst Rises on Positive Ebola Candidate Results - Analyst ...

    December 26, 2014
    Shares of BioCryst Pharmaceuticals (BCRX) rallied 6.9% after the announcement of results from a study on its Ebola virus ...
  4. Synergy Starts SP-333 Phase I Study - Analyst Blog

    January 29, 2013
    Synergy Pharmaceuticals Inc. (SGYP) recently initiated a phase Ib study on its inflammatory bowel disease (IBD) candidate, ...
  5. Isis Pharma Updates on its Pipeline - Analyst Blog

    January 11, 2013
    Isis Pharmaceuticals, Inc. (ISIS) recently provided an update on its pipeline. Isis Pharma boasts of a robust pipeline. The ...
  6. Find A Biotech Stock That's On A Winning Streak

    March 22, 2012
    Investors follow momentum trends because positive sentiment on a company can cause the momentum to persist.
  7. 6 Stocks At 52-Week Lows

    January 31, 2011
    Are these companies on a downward spiral or gearing up for a rebound?
  8. Flu Stocks Looking Sickly

    December 16, 2009
    Flu Stocks Looking Unhealthy
  9. Four High-Flying Pharmaceutical Companies

    October 28, 2009
    A look at some of the best-performing stocks year to date - up anywhere from 400% to 2000%.
Trading Center